Emtricitabine Oral Solution shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-06-17 · last update 2026-06-17
Manufacturers: Gilead Sciences, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Emtriva, Oral Solution, 10 mg/1 mL (NDC 61958-0602-1) | Gilead Sciences, Inc. | To Be Discontinued | — | Product expected to be available until March 2027 | Posted 06/17/2026 Updated 06/17/2026 Discontinued 06/17/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)